Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
After finishing at $3.60 in the prior trading day, IN8bio Inc (NASDAQ: INAB) closed at $4.17, up 15.74%. In other words, the price has increased by $15.74 from its previous closing price. On the day, 0.52 million shares were traded.
Ratios:
Our goal is to gain a better understanding of INAB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.00 and its Current Ratio is at 4.30. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.22.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Laidlaw on March 18, 2024, initiated with a Buy rating and assigned the stock a target price of $7.50.
On August 30, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $14.
Stock Price History:
Over the past 52 weeks, INAB has reached a high of $52.20, while it has fallen to a 52-week low of $3.03. The 50-Day Moving Average of the stock is -11.00%, while the 200-Day Moving Average is calculated to be -47.70%.
Shares Statistics:
A total of 3.44M shares are outstanding, with a floating share count of 3.26M. Insiders hold about 5.80% of the company’s shares, while institutions hold 15.50% stake in the company.
